1393739-32-6Relevant articles and documents
Development of energetic pharmacophore for the designing of 1,2,3,4-tetrahydropyrimidine derivatives as selective cyclooxygenase-2 inhibitors
Lokwani, Deepak,Shah, Reecha,Mokale, Santosh,Shastry, Padma,Shinde, Devanand
, p. 267 - 277 (2012/07/17)
We present here the Energetic pharmacophore model representing complementary features of the 1,2, 3,4-tetrahydropyrimidine for selective cyclooxygenase-2 (COX-2) inhibition. For the development of pharmacophore hypothesis, a total of 43 previously reporte